Experiments were carried out in the dog by the use of experimental procedure which permits to assess independently changes in uretheral peristaltic frequency, bolus volume and intraluminal pressure and flow volume in order to characterize a-adrenoceptor subtypes involved in regulation of ureteral urine transport. Norepinephrine caused an increase in ureteral peristaltic fregency, an elevation in intraureteral baseline and contractile pressure and a decrease in bolus volume, with a resultant decrease in the rate of fluid transport. Phenylephrine (al-agonist) and clonidine (a2-agonist) caused the effects similar to those of norepinephrine on peristaltic frequency, intraureteral baseline and contractile pressure, and bolus volume. Phentolamine (non-selective a-antagonist) and prazosin (a,-antagonist) caused a decrease in ureteral peristaltic frequency, and a fall in intraureteral baseline and contractile pressure, and yohimbine (a2-antagonist) abolished peristalsis and bolus formation. These changes were accompanied by an increase in the rate of fluid transport. These data suggest that the ureteral urine transport is controlled by activation of both al-and a2-adrenoceptors through regulation of peristaltic frequency and bolus volume, ureteral urine transport ; a-adrenoceptor subtypes
The role of a-adrenoceptor subtypes involved in the control of ureteral function has not been fully elucidated while it is reported that norepinephrine causes an increase in the frequency of ureteral peristalsis in ureteral pressure (Boatman et al. 1967; Kaplan et al. 1968; Tindall 1972; Hannappel and Golenhofen 1974; Reid et al. 1974; Rose and Gillenwater 1974; Tsuchida and Sakamoto 1974; Mayo and Halbert 1981) . We have recently developed an experimental model which permits to assess changes in ureteral peristaltic frequency and bolus volume independently . The present study was designed to characterize a-adrenoceptor subtypes involved in the control of the ureteral urine transport by assessing various parameters to affect the urine transport, i.e., bolus volume, peristaltic frequency, intraluminal pressure and flow volume.
MATERIALS and METHODS
Twenty eight adult mongel dogs of both sexes, weighing 6 to 10 kg, were anesthetized with intravenous thiamylal sodium 15 mg/kg and pancuronium 0.1 mg/kg and maintained by controlled respiration. The blood pressure was recorded via a Statham P-50 pressure transducer coupled to a polyethylene catheter inserted into the left femoral artery. The left kidney and ureter were exposed via laparotomy and an indwelling doublelumen polyethylene catheter was passed into the renal pelvis through a nephrostomy. One lumen of the catheter was connected to a large reservoir which was designed to maintain a constant fluid level so as to permit a continuous intrapelvic infusion of physiologic saline at a constant pressure of 10 cmH2 0. The other lumen was coupled to a Statham P-50 transducer to record intrapelvic pressure, when necessary. A 5 Fr ureteral catheter was inserted transvesically, for a distance of 5 mm, into the left ureterovesical junction. The end of the ureteral catheter was connected to a drop counter. :Bolus volume and fluid flow volume per unit time were determined by integration of recorded drop counts. Ureteral electromyograms were also recorded extraluminally with platinum biopolar electrodes placed on the midportion of the left ureter. A 22 gauge needle bent in an L-shape, 4 mm from its tip, was inserted into the midportion of the ureter so that its 4 mm tip portion alone lay in the ureteral lumen. The base of the L-shaped needle was connected to a Statham P-50 transducer for intraureteral pressure measurements. Finally the left renal vein was ligated to arrest urine secretion from the left kidney (Fig. 1 ). Drugs were administered intravenously. The drugs used and their doses were as follows : 1-norepinephrine bitartrate 5 pg/kg, 1-phenylephrine hydrochloride 10 p g/kg, clonidine hydrochloride 10 p g/kg, phentolamine hydrochloride 100pg/kg, yohimbine hydrochloride 100pg/kg. Phentolamine hydrochloride was from Ciba-Geigy, prazosin hydrochloride was from Pfizer and other drugs were from Sigma. Agonists were dissolved in distilled water, containing 1 mg/ml ascorbic acid and antagonists were dissolved in 75% ethanol to give a concentration of 10 M and then diluted to the desired concentration with distilled water. The concentrations of drugs administred were chosen based on experiments on the ureter by previous investigators (Boatman et al. 1967; Kaplan et al. 1968; Tindall 1972; Hannappel and Golenhofen 1974; Reid et al. 1974; Rose and Gillenwater 1974; Tsuchida and Sakamoto 1974; Mayo and Halbert 1981; Morita et al. 1985 
RESULTS
Ligation of the left renal vein induced a temporary increase in left renal pelvic pressure, ureteral peristaltic frequency and bolus volume with a resultant temporary increase in urine flow. In a few minutes, urine flow stopped and renal pelvic pressure and ureteral peristaltic frequency gradually decreased to the levels noted before ligation (Fig. 2) . Representative tracings of blood pressure, renal pelvic pressure, ureteral electromyograms and fluid output (drop counts) obtained from a dog which received norepinephrine are shown in Fig. 3 . The effects of norepinephrine, phenylephrine and clonidine are summarized in Table 1 . There was a 43% decrease in the ureteral peristaltic interval and a 55% decrease in bolus volume with a resultant 22% decrease in the fluid flow rate following the injection of norepinephrine 5 u g/kg (n = 5). In response to the injection of phenylephrine 10 ,u g/kg (n = 5) there was a 46% decrease in the ureteral peristaltic interval and a 57% decrease in bolus volume with a resultant 27% decrease in the fluid flow rate. Norepinephrine and phenylephrine significantly increased the blood pressure. Clonidine 10 ,u g/kg (n = 5) produced a 53% reduction in the peristaltic discharge interval, a 65% decrease in bolus volume and a 16% decrease in the rate of fluid transport. Clonidine significantly decreased the blood pressure. Phentolamine 1001u g/kg (n = 4) caused a 67% prolongation of the ureteral discharge interval, an 84% increase in bolus volume and an 18% increase in the rate of fluid transport. Prazosin 100 ,u g/kg (n = 5) caused an 84% prolongation of the ureteral discharge interval, a 98% increase in bolus volume and a 9% increase in the rate of fluid transport. In response to the injection of yohimbine Effect of Phentolamine, Prazosin and val, bolus volume and fluid flow yohimb me on ureteral peristaltic inter-100 p g/kg (n = 4), ureteral peristalsis disappeared during which period fluid continued to drip out of the ureter without bolus formation. The rate of fluid transport increased by 12% (Table 2) .
In 26 of 28 dogs receiving agonists or antagonists the intraureteral pressure was recorded following administration of another dose of drug, 2 hr after the first injection. As seen in Fig. 4 (representative tracings with norepinephrine 51ag/ kg) and Table 3 , the intraureteral baseline and contractile pressure showed a 45% and 55% increase, respectively, following norepinephrine 5 p g/kg (n = 3) and a 58% and 9% increase, respectively, following phenylephrine 101u g/kg (n = 5). Clonidine 10 p g/kg (n = 5) also increased the baseline and contractile pressure by 33% and by 11%, respectively. Prazosin 100 p g/kg (n = 4) decreased the intraureteral baseline pressure by 20% and the intraureteral contractile pressure by 20%, respectively. Yohimbine 100 p g/kg (n =4) decreased the baseline pressure by 7% and the contractile pressure by 19%, respectively (Table 4) . 
DISCUSSION
The design of the experimental procedure is important in assessing responses of the ureter to drugs, in vivo. This is because urine secretion varies with drug administration and the altered urine volume gives rise to changes in ureteral peristaltic frequency and bolus volume (Briggs et al. 1972 ; Morita et al. 1985) . With the method in which lactate-Ringer solution is continuously infused into the renal pelvis at a content rate (Mayo and Halbert 1981) , it is difficult to completely eliminate changes in urine volume evoked by drugs, and the peristaltic frequency and bolus volume can not be assessed independently.
We developed experimental procedure that permitted to assess changes of ureteral peristaltic frequency and bolus volume independently.
This method involved infusing saline into the renal pelvis at a constant pressure rather than at a constant rate of flow. These conditions are necessary because if the fluid is infused into the renal pelvis at a constant rate, any changes in ureteral peristaltic frequency eventually lead to a change in bolus volume, since (ureteral peristaltic frequency) X (Bolus volume) _ (Amount of fluid infused).
In the experimental system we designed, norepinephrine (5 p g/kg) and phenylephrine (10 p g/kg) significantly increased ureteral peristaltic frequency, reduced bolus volume and decreased fluid transport. Clonidine (10 p g/kg) also increased ureteral peristaltic frequency reduced bolus volume and decreased fluid transport. Norepinephrine and phenylephrine caused an elevation of blood pressure, whereas clonidine caused a small but significant fall in blood pressure. Phentolamine (100 p g/kg) and prazosin (100 p g/kg) both produced a decrease in ureteral peristaltic frequency and an increase in bolus volume and fluid transport. Yohimbine (100 p g/kg) caused a disappearance of ureteral peristalsis and bolus formation, and an increase in fluid transport. Prazosin caused a fall in blood Effect of prazosine and yohim bine on ureteral pressure pressure, whereas yohimbine did not affect the blood pressure. Norepinephrine, phenylephrine, and clonidine, all produced an elevation in baseline and contractile pressure, while both prazosin, and yohimbine, produced a small fall in baseline and contractile pressure. It has been reported that norepinephrine, a relatively selective aadrenoceptor agonist, causes an increase in frequency of ureteral peristalsis and in ureteral pressure in vivo (Boatman et al. 1967 ; Kaplan et al. 1968 ; Tindall 1972; Hannappel and Golenhofen 1974 ; Reid et al. 1974 ; Rose and Gillenwater 1974; Tsuchida and Sakamoto 1974; Mayo and Halbert 1981) . However, previous studies carried out in the ureter have not addressed the subtypes of aadrenoceptors involved in changes in a-adrenoceptor-induced activities. It is generally accepted that al-adrenoceptors exist postsynaptically and a2-adrenoceptors exist presynaptically (Berthelsen and Pettinger 1977; Hoffman et al. 1979; Wikberg 1979) . Recent studies, however, have suggested the existence of postsynaptic a2-adrenoceptors (DeMey and Vanhoutte 1981; Skarby et al. 1983) . Our data have shown that both al-and a2-adrenoceptor stimulation cause an increase in ureteral peristaltic frequency and an elevation of ureteral pressure, reduce bolus volume and decrease urine transport. The present findings that both the al-adrenoceptor antagonist, prazosin, and the a2-adrenoceptor antagonist, yohimbine, inhibited the ureteral activity and increased the rate of ureteral fluid transport further support the view that changes in activities caused by stimulation of a-adrenoceptors in ureter are related to both subtypes, i.e., al-and a2-adrenoceptors. Our data also indicate that a-adrenoceptor agonists, which have been generally thought to have a favorable effect on urine transport, by enhancing the ureteral peristaltic frequency and contractile force, actually lower the rate of urine transport by reducing bolus volume. The findings that al-or a2-adrenoceptor antagonist inhibited the ureteral activity by itself may indicate that the ureteral activity is basically brought under a certain tonic control through synpathetic nervous system. 
